Hideyuki Okuma

Serum‐derived microribonucleic acids as potential novel biomarkers for slowly progressive type 1 diabetes mellitus

OBJECTIVES: We aimed to identify microribonucleic acids (miRNAs) that could serve as biomarkers for slowly progressive type 1 diabetes mellitus (SPIDDM). MATERIALS AND METHODS: We conducted a retrospective study of adult patients with SPIDDM who fulfilled the criteria for SPIDDM...